Antibody-drug conjugates in the perioperative treatment of resectable non-small cell lung cancer: a narrative review of research advances and prospects.

Xiong Y, Sun L, Peng Y

Open source

DOI
10.21037/tlcr-2026-1066
Published
2026 Oct 30
Container
Translational lung cancer research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/tlcr-2026-1066,
  title = {Antibody-drug conjugates in the perioperative treatment of resectable non-small cell lung cancer: a narrative review of research advances and prospects.},
  author = {Xiong Y and Sun L and Peng Y},
  year = {2026},
  journal = {Translational lung cancer research},
  doi = {10.21037/tlcr-2026-1066},
  url = {https://doi.org/10.21037/tlcr-2026-1066}
}

RIS

TY  - JOUR
TI  - Antibody-drug conjugates in the perioperative treatment of resectable non-small cell lung cancer: a narrative review of research advances and prospects.
AU  - Xiong Y
AU  - Sun L
AU  - Peng Y
PY  - 2026
JO  - Translational lung cancer research
DO  - 10.21037/tlcr-2026-1066
UR  - https://doi.org/10.21037/tlcr-2026-1066
ER  - 

APA

Y, X., L, S., & Y, P. (2026). Antibody-drug conjugates in the perioperative treatment of resectable non-small cell lung cancer: a narrative review of research advances and prospects.. Translational lung cancer research. https://doi.org/10.21037/tlcr-2026-1066

Source records